Results 71 to 80 of about 34,651 (222)

Trends and uptake of new formulations of controlled-release oxycodone in Canada [PDF]

, 2018
Purpose: This study investigated the impact of changing availability of tamper‐deterrent and non‐tamper‐deterrent oxycodone on prescribing patterns of controlled‐release oxycodone across Canada.
Caetano, Patricia, CNODES Investigators, Gomes, Tara, Henry, David, Jain, Sonia, Paterson, J. Michael, Sketris, Ingrid   +6 more
core   +2 more sources

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

British Journal of Clinical Pharmacology, EarlyView.
Christina Gao, Ashley M. Hopkins, Andrew Rowland, Stephen Bacchi   +3 more
wiley   +1 more source

Relief of pain associated with spasticity in adult patients after treatment with onabotulinumtoxinA: Post hoc observational results from the ASPIRE study

PM&R, EarlyView.
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel, Cassandra List, Marc Schwartz, Mariana Nelson, Tiziana Musacchio, Esther Duarte   +5 more
wiley   +1 more source

Off-Label Use of Dalbavancin in Enterococcus spp. Abscess and Streptococcus pneumoniae Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report

Pharmacoepidemiology
Dalbavancin, a semi-synthetic lipoglycopeptide with an extended half-life that allows for weekly dosing, is currently approved for the treatment of bacterial skin and soft tissue infections caused by susceptible gram-positive organisms.
Miriam Banoub Morkos, Giovani Leon, Mai-Chi Hong, Joshua Allan Garcia, Martin J. Breen, Bhanu Sud, Lee Nguyen   +6 more
doaj   +1 more source

Ophthalmic adverse drug reactions to systemic drugs: a systematic review [PDF]

, 2014
PURPOSE: To perform a comprehensive and systematic review regarding ophthalmic adverse drug reactions (ADRs) to systemic drugs to: (i) systematically summarize existing evidence, (ii) identify areas, ophthalmic ADRs or drugs that lacked systematization ...
Azevedo, LF, Henriques, F, Miguel, A, Pereira, AC   +3 more
core   +1 more source

Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population‐Based Registry Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To estimate miscarriage risk following gestational antimicrobial exposure while addressing biases that have affected previous studies. Design Population‐based cohort study. Setting Linkage of four nationwide registries: Medical Birth Registry of Norway (MBRN), Norwegian Prescribed Drug Registry (NorPD), Norwegian Patient Registry ...
Thomas Boissiere‐O'Neill, Marleen M. H. J. van Gelder, Hilde M. Engjom, Hedvig M. E. Nordeng   +3 more
wiley   +1 more source

Association of Receipt of Opioid Prescription for Acute Post-Delivery Pain Management with Buprenorphine Discontinuation among Postpartum People with Opioid Use Disorder

Pharmacoepidemiology
Buprenorphine is a safe and effective medication to treat opioid use disorder (OUD) in pregnant patients and is intended to be continued throughout pregnancy, delivery, and at least the one-year postpartum period.
Taylor N. Hallet, David T. Zhu, Hannah Shadowen, Lillia Thumma, Madison M. Marcus, Amy Salisbury, Caitlin E. Martin   +6 more
doaj   +1 more source

Stroke risk and NSAIDs: A systematic review of observational studies [PDF]

, 2011
Aims: To perform a quantitative systematic review of observational studies on the risk of stroke associated with the use of individual NSAIDs.
Calingaert, B. (Brian), Castellsague, J. (Jordi), Pariente, A. (Antoine), Perez-Gutthann, S. (Susana), Riera-Guardia, N. (Nuria), Scotti, L. (Lorenza), Sturkenboom, M.C.J.M. (Miriam), Varas-Lorenzo, C. (Cristina)   +7 more
core   +3 more sources

Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Smoking is the leading preventable cause of premature death in China, yet less than 10% of smokers seeking to quit receive treatment. This study aimed to test the efficacy of a cognitive behavioral therapy (CBT)‐based smoking cessation intervention (‘Smokefree Life’) via a smartphone app in China. Design A digital, parallel,
Jinsong Tang, Xiaocong Liu, Shanshan Chen, Yunkai Sun, Minzhe Zhu, Zitang Zhou, Yueheng Liu, Jie Yang, Wei Chen, Yanhui Liao   +9 more
wiley   +1 more source

Rescue Therapy for Supratherapeutic Concentrations of Calcineurin Inhibitors Using Potent Cytochrome P450 Inducers

Pharmacoepidemiology
Introduction: Calcineurin inhibitors (CNIs), ciclosporin and tacrolimus, are utilized primarily in organ transplantation and the treatment of autoimmune diseases.
Seth Duwor, Katharina Enthofer, Christoph Ganter, Prabin Poudel, Anna Svarin, Gerd A. Kullak-Ublick   +5 more
doaj   +1 more source